FDA Axes 1970s Orange Dye No One Used for Sausages
Published Date: 9/17/2025
Proposed Rule
Summary
The FDA wants to stop allowing Orange B as a color for frankfurter and sausage casings because it hasn’t been used since 1978. This change affects food makers who might have used Orange B, but since it’s basically retired, there’s no big cost or hassle. The FDA is confident this cleanup keeps food rules fresh and clear.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Orange B Color Use Removed
The FDA proposes to remove the rule that allows the color additive Orange B to be used on frankfurter and sausage casings. The agency says Orange B has not been certified for use in U.S. food marketed since 1978, so food makers who might once have used it would no longer be allowed to use it.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16728, Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended as an Aid for Detection of Bladder Cancer
The Food and Drug Administration (FDA) is proposing to reclassify diagnostic endoscopic light source systems (product code OAY), which are postamendments class III devices, from class III (premarket approval) into class II (special controls), subject to premarket notification. FDA is also proposing a new device classification regulation with the name "Cystoscopic system intended as an aid for detection of bladder cancer," along with special controls that FDA believes are necessary to provide a reasonable assurance of the safety and effectiveness of these devices.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16727, Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product
The Food and Drug Administration (FDA, the Agency, or we) is issuing a final order reclassifying in situ hybridization (ISH) test systems indicated for use with a corresponding approved oncology therapeutic product (product codes NYQ, MVD, OWE, and PNK), all postamendments class III (premarket approval) devices, into class II (special controls), subject to premarket notification. FDA is also establishing a new device classification regulation, along with the special controls that are necessary to provide a reasonable assurance of safety and effectiveness of this device type.
Previous / Next Documents
Previous: 2025-17960, Proposed Priority and Definitions-Secretary's Supplemental Priority and Definitions on Promoting Patriotic Education
The Secretary is adding a new priority to support patriotic education in current and future grant programs. This means schools and organizations applying for education grants might see new ways to get funding focused on teaching American history and values. Keep an eye out for updates starting in late 2025 that could bring fresh money and opportunities your way!
Next: 2025-18056, Hawaii: Final Approval of State Underground Storage Tank Program Revisions, Codification, and Incorporation by Reference
Hawaii just got the green light from the EPA for updates to its Underground Storage Tank Program, which helps keep underground fuel tanks safe and leak-free. These changes clarify which state rules are part of the program and officially include them in federal records. Tank owners and operators in Hawaii should know these updates are now official, helping protect the environment without adding new costs or deadlines.